Solborn

035610 · KOSDAQ · ₩035610 · 솔본

₩4,805▲ ₩5 (0.10%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y +20.73%
Market cap
₩131B
Enterprise value
−₩86B
P/E
3.7×
P/B
0.5×
Dividend yield
0.0%
ROE
14.6%
Net margin
28.0%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−14.2% from the high

₩3,155Today: ₩4,715 – ₩4,855₩5,600

Returns

  • 1W+1.5%
  • 1M−4.3%
  • 3M+5.6%
  • 6M+26.9%
  • YTD+31.8%
  • 1Y+20.7%
Volume today
6,345
0.3× the 20-day average
Traded today
₩30M
Listed shares
27,345,997
EPS (12 months)
₩1,288
Earnings yield 26.8%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

31Quiet
  • BuzzQuietBuzz 31 of 100 (50 is a normal day for this stock).
  • MomentumFlat-5% over the last month; the price is above its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Solborn stock overview

Solborn (솔본, KRX: 035610) is listed on KOSDAQ, in the Business services sector. The company is a Korean holding company that owns and manages specialized subsidiaries in medical IT, venture capital and overseas listed-stock investment, aiming to raise corporate value through their growth. Its shares closed at ₩4,805 on Oct 29, 2026, up 0.10% on the day, giving it a market value of ₩131B.

Key facts

Market cap
₩131B
Sector
Business services
Latest price change
+0.10%
As of
Oct 29, 2026
Main business
The company is a Korean holding company that owns and manages specialized subsidiaries in medical IT, venture capital and overseas listed-stock investment, aiming to raise corporate value through their growth.

Quick answers about Solborn

What does Solborn do?
The company is a Korean holding company that owns and manages specialized subsidiaries in medical IT, venture capital and overseas listed-stock investment, aiming to raise corporate value through their growth. Its main subsidiary, Infinite Healthcare, makes PACS medical imaging systems that digitize, store and transmit medical images for hospitals, and it also leases the Cheongdam headquarters building. The company operates in Seoul and invests in unlisted ventures and overseas listed shares through Solborn Investment and Solborn Investment, Inc.
What is the market cap of Solborn?
The market capitalisation of Solborn was ₩131B at the close on Oct 29, 2026.
Who are the largest shareholders of Solborn?
According to the latest official filings, the largest reported holders are Hong Ki-tae (72.37%, as of Sep 21, 2026); Lee Hye-suk (15.79%, as of Jan 29, 2026); Focus Newspaper (12.46%, as of Sep 11, 2026).
When is the next earnings report from Solborn?
Korean companies rarely announce results dates in advance. Based on when Solborn filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.

Company profile

The company is a Korean holding company that owns and manages specialized subsidiaries in medical IT, venture capital and overseas listed-stock investment, aiming to raise corporate value through their growth. Its main subsidiary, Infinite Healthcare, makes PACS medical imaging systems that digitize, store and transmit medical images for hospitals, and it also leases the Cheongdam headquarters building. The company operates in Seoul and invests in unlisted ventures and overseas listed shares through Solborn Investment and Solborn Investment, Inc.

Written by AI from the company's latest annual report.

Korean name
솔본
Themes
—
CEO
홍 기 태
Founded
Aug 1994
Listed
Aug 1999
Listed shares
27,345,997
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Solborn / 솔본 / 035610 / KRX:035610

Source: KRX statistical information